Skip to content

Comparison of One-puncture Ultrasound-Guided Rectus Sheath Block with Transversus Abdominis Plane Block versus Control group for Post-operative Pain control after Laparoscopic Cholecystectomy: A Randomized Controlled Trial

Comparison of One-puncture Ultrasound-Guided Rectus Sheath Block with Transversus Abdominis Plane Block versus Control group for Post-operative Pain control after Laparoscopic Cholecystectomy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260515008
Enrollment
84
Registered
2026-05-15
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative analgesia with opioid sparing technique for laparoscopic cholecystectomy Laparoscopic cholecystectomy, Rectus Sheath Block, Transversus Abdominis Plane Block

Interventions

One-puncture Ultrasound-Guided Rectus Sheath Block with Transversus Abdominis Plane Block with 0.25% Bupivacaine 10 ml for RSB and 15 ml for TAP block total 25 ml/side ,Standard Multimodal analgesia i
Experimental Procedure/Surgery,No Intervention No treatment
Rectus Sheath Block with Transversus Abdominis Plane Block group,Control group

Sponsors

Research Division Faculty of Medicine Srinakarinwirot University
Lead Sponsor
Faculty of Medicine, Srinakarinwirot University
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 20 and 70 years with ASA physical status I, II, or III 2. Undergoing elective laparoscopic cholecystectomy under general anesthesia with endotracheal tube intubation and controlled ventilation admitted as in-patients (In patient Department) only. 3. Able to voluntarily provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal coagulation. 2. Patients with a history of allergy to local anesthetics or any medications used in this study. 3. Patients with infection at the intended site of local anesthetic injection. 4. Patients with a history of chronic opioid use for more than 3 months. 5. Patients unable to communicate effectively (e.g., severe dementia, language barriers) or unable to use a Patient Controlled Analgesia (PCA) pump. 6. Patients with severe renal impairment (chronic kidney disease stage >3B) or requiring renal replacement therapy. 7. Patients with severe hepatic failure (Child-Pugh class C). 8. Pregnant or breastfeeding patients. 9. Patients weighing less than 45 kg. 10. Patients with a body mass index (BMI) greater than 40 kg/m2. 11. Cases in which the preparation process or procedural performance results in a surgical delay of more than 30 minutes.

Design outcomes

Primary

MeasureTime frame
Total opioid consumption 24 hours postoperatively Data regarding opioid consumption were retrieved from the IV-PCA infusion pumps.

Secondary

MeasureTime frame
Numeric rating scale 6,12,24 hours Pain intensity was assessed via the 11-point Numerical Rating Scale (NRS).,Postoperative nausea and vomiting 24 hours Observe the patient for symptoms of PONV.,Complication 24 hours Observation of Regional Anesthesia-Related Complications,Satisfaction 24 hours Patient satisfaction was measured using a five-point Likert scale.

Countries

Thailand

Contacts

Public ContactNudtapod Rutanaburee

Faculty of Medicine, Srinakarinwirot university

nurngnoi@gmail.com0858184868

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026